Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from CMS

They openly ripped off Medicare

Health plans will be allowed to pocket hundreds of millions of dollars in overcharges for audits before 2018

Salon

DWP announces big changes to the way child maintenance is paid

Plans to protect parents from abusive ex-partners come after coroner calls for reform following the tragic death of Emma Day

Chronicle Live

Medicare Advantage plans overcharged government hundreds of millions but get to hang onto the money

The federal Medicare agency will require next to nothing from insurers for excess payments they got from 2011 to 2017 and won’t impose big penalties until audits for 2018 and beyond are conducted, which could be years.

Chicago Sun-Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Commentary: We shouldn’t get caught up in the hype over new Alzheimer’s drug

This month, the Food and Drug Administration approved a new drug, lecanemab, for the treatment of Alzheimer’s disease. The drug, sold under the brand name Leqembi, was developed by Japanese pharmaceutical company Eisai and will be marketed commercially in partnership with American pharmaceutical company Biogen. Biogen, notably, is the maker…

Chicago Tribune

Did your health plan rip off Medicare?

Previously secret government audits reveal millions of dollars in overpayments to Medicare Advantage health plans

Salon

Energy transition presents Scotland's 'most significant' challenges and opportunities

Panel of experts at Insider breakfast event states that existing oil and gas industry must be supported in move to renewables

Insider UK

Commentary: Too soon to celebrate new Alzheimer’s drug

A treatment that improves Alzheimer’s disease would be a great advance, but Leqembi (lecanemab), which recently received accelerated approval from the FDA, is not that drug. Yes, lecanemab slows decline to an extent detectable on a test, but not to an extent that a relative or caretaker would notice. This…

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Feds to investigate nursing home abuse of antipsychotics

The federal government says it will begin a targeted crackdown on nursing homes’ abuse of antipsychotic drugs and misdiagnoses of schizophrenia in patients

The Independent UK

'No dominant model' for hybrid work has yet emerged

A new survey of the financial and professional services sector finds most firms are not enforcing minimum number of office days

Insider UK

New child maintenance laws to protect domestic abuse survivors

The measures are aimed at stopping perpetrators from using child maintenance as a form of ongoing financial abuse and control

Wales Online

New measures to support domestic abuse survivors make child maintenance claims

The Independent UK

Illinois Medicaid contractor Centene Corp. under federal scrutiny over foster kids’ medical care

An Illinois Answers Project investigation found that the insurance giant fell short in providing basic care. Now, federal officials want answers from state agencies overseeing the program.

Chicago Sun-Times

FDA grants fast-track approval to experimental Alzheimer's drug

The FDA approved lecanemab, which has shown to slow the progression of Alzheimer's disease.

Axios

Providers say Medicare Advantage hinders new methadone benefit

In 2018, responding to a wave of overdose deaths, Congress passed legislation requiring Medicare to pay for services at opioid treatment programs for the first time.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Roll Call

Providers say Medicare Advantage hinders new methadone benefit

A new benefit aimed at helping treat opioid use disorder can be hard to access for those who use Medicare Advantage plans, advocates say.

Dynamite News

Recruitment Of Maoist Cadres: NIA Files Chargesheet Against 5 Persons

The National Investigation Agency (NIA) has filed a charge sheet against five persons in a case linked to the radicalization and recruitment of innocent youth into the Communist Party of India (Maoist). Read on for details:

Salon

Did Medicare Advantage plans overcharge?

Some Medicare Advantage plans failed to produce any records to justify their payments, government records show

Tribune News Service

How Medicare Advantage plans dodged auditors and overcharged taxpayers by millions

In April 2016, government auditors asked a Blue Cross Medicare Advantage health plan in Minnesota to turn over medical records of patients treated by a podiatry practice whose owner had been indicted for fraud.

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

Medicare Advantage health plans dodged auditors, overcharged taxpayers millions

A review of 90 government audits reveals the plans have repeatedly tried to get around mandates to document medical conditions the government paid them to treat.

Salon

The Medicare Advantage plan scandal

Health insurers that issue Medicare Advantage plans have repeatedly tried to sidestep regulations, audits find

WEKU

How Medicare Advantage plans dodged auditors and overcharged taxpayers by millions

A KHN investigation found when some Medicare Advantage plans got a rare federal audit, they couldn't produce billing records for care they said they'd provided. Some blamed fire, flood — or doctors.

Tribune News Service

Pagan nurse files religious discrimination lawsuit

LAS VEGAS — A Las Vegas nurse and self-described pagan has sued the hospital that fired her after it rejected her request for a religious exemption to its COVID-19 vaccination requirement.

Tribune News Service

Older adults face Medicare hurdles for substance use treatment

For the staff at the Senior Recovery Center in Maplewood, Minnesota, helping older adults overcome substance use disorders is a calling, said Christine Martinek, a licensed alcohol and drug counselor there.

Insider UK

More panellists revealed for Insider's Business Breakfast

The event in January will feature a keynote speech, panel discussion and Q&A session

Axios

New Alzheimer's drug faces uncertain regulatory path

The FDA will soon decide whether to approve Eisai's experimental drug lecanemab.

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

338 stories

Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.